<img height="1" width="1" style="display:none;" alt="" src="https://px.ads.linkedin.com/collect/?pid=2653956&amp;fmt=gif">
Image Overlay - Is Regulatory Harmonization Between the FDA and the EMA Decreasing?
Image Overlay - Is Regulatory Harmonization Between the FDA and the EMA Decreasing?

Is Regulatory Harmonization Between the FDA and the EMA Decreasing?

September 11, 2019

Is Regulatory Harmonization Between the FDA and the EMA Decreasing?

Although the two agencies have historically agreed on over 90% of new drug approvals, a new study conducted by the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) suggests that the EMA may be less likely to approve new drugs than the FDA. Regulatory harmonization is a critical concern for Yourway’s customers engaged in international clinical trials.

 Back to Index
Stay Connected

Want to stay informed about the latest news, updates, and opportunities at Yourway?

Join our newsletter mailing list to never miss an update!

Media

Upcoming Events

Clinical Trial Supply West Coast

September 22-23, 2026
Burlingame, CA

GCSG 2026 European Knowledge Forum

October 14-15, 2026
Rome, Italy

Media

Articles

Your Clinical Trial Has 99 Problems. Logistics Shouldn’t Be One.

Open chat
Come chat with us!
Hello! How can I help you?